| Period Ending | 31 Mar 2013 | 31 Dec 2012 | 30 Sep 2012 | 30 Jun 2012 |
|---|
|
Total Revenue
|
20,489,000
|
21,456,000
|
16,008,000
|
18,059,000
| | Cost of Revenue | 4,787,000 | 5,692,000 | 4,168,000 | 4,163,000 | | |
Gross Profit
|
15,702,000
|
15,764,000
|
11,840,000
|
13,896,000
| |
|
Operating Expenses |
|
Research Development | 2,640,000 | 2,528,000 | 2,460,000 | 2,594,000 |
|
Selling General and Administrative | 5,450,000 | 5,465,000 | 4,072,000 | 4,917,000 |
|
Non Recurring |
-
|
-
|
-
| 6,193,000 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
7,612,000
|
7,771,000
|
5,308,000
|
192,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (9,000) | (1,000) | 226,000 | 167,000 |
|
Earnings Before Interest And Taxes | 7,603,000 | 7,770,000 | 5,534,000 | 359,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 7,603,000 | 7,770,000 | 5,534,000 | 359,000 |
|
Income Tax Expense | 1,548,000 | 1,393,000 | 1,068,000 | 851,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 6,055,000 | 6,377,000 | 4,466,000 | (492,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
6,055,000
|
6,377,000
|
4,466,000
|
(492,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
6,055,000
|
6,377,000
|
4,466,000
|
(492,000)
|
|
0.63%